DNA Diagnostic

HemaVision® | Fast diagnostic kits for screening of Leukemia-associated translocations

DNA Diagnostic A/S is the manufacturer of HemaVision®, a range of diagnostic kits for screening of translocations associated with Leukemia.

The HemaVision® range can detect up to 28 translocations in just 4 hours, ensuring fast diagnostics and subsequent treatment. HemaVision screens for the most common, as well as rare, translocations and fusion genes.

DNA Diagnostic A/S believes the world deserves fast, cost-effective and reliable diagnostics.

DNA Diagnostic A/S is ISO 13485 certified. HemaVision® products are CE IVD marked and have received a Free Sales Document.

HemaVision® Leukemia Screening Tool

We see an increased demand for a reliable screening tool to detect chromosomal translocations associated with Leukemia. This can be achieved by HemaVision, fast and efficiently, by a simple and rapid protocol.

Bio-Connect Diagnostics supplies HemaVision® products in the Benelux. If you have any questions, please contact the helpdesk.

September is Leukemia awareness month

Becoming ill is a difficult situation for the patient and their relatives. Waiting for the diagnosis is an extremely hard period. HemaVision 28Q helps to an early diagnosis of Leukemia.

Benefits by getting an early diagnosis

  • Better response to the treatment
  • Less complications
  • Improved quality of life
  • Increased survival rate
  • Less aggressive treatment

HemaVision 28Q is a diagnostic tool. It screens for 28 genomic translocations associated with Leukemia. Results in only 4 hours.

More about DNA Diagnostic

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support